Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
Main Authors: | Sodiomon B. Sirima, Alfred B. Tiono, Alphonse Ouédraogo, Amidou Diarra, André Lin Ouédraogo, Jean Baptiste Yaro, Espérance Ouédraogo, Adama Gansané, Edith C. Bougouma, Amadou T. Konaté, Youssouf Kaboré, Abdoulaye Traoré, Chilengi Roma, Issiaka Soulama, Adrian J. F. Luty, Pierre Druilhe, Simon Cousens, Issa Nébié |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862746/?tool=EBI |
Similar Items
-
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.
by: Sodiomon B Sirima, et al.
Published: (2009-10-01) -
Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children.
by: Sodiomon B. Sirima, et al.
Published: (2010-01-01) -
Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso
by: Issiaka Soulama, et al.
Published: (2015-01-01) -
Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso
by: Diarra Amidou, et al.
Published: (2012-05-01) -
Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies
by: Adama Gansane, et al.
Published: (2013-08-01)